MeSH tree: D06.472.699.587.334
Often dismissed as a minor ailment, migraine is a debilitating neurological disease affecting hundreds of thousands of New Zealanders. At the University of Otago's School of Biomedical Sciences, world-leading research by ...
Nov 17, 2025
0
0
Amylin, a hormone that controls appetite and blood sugar by activating three different receptors in the brain, could be the basis for the next blockbuster obesity drugs. A University of Oklahoma study published in the journal ...
Aug 19, 2025
0
47
The holidays are full of delicious and indulgent food and drinks. It's hard to resist dreaming about cookies, specialty cakes, rich meats and super saucy side dishes.
Nov 25, 2024
0
16
The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been shown to lead to significant weight loss in users—as much as 15% or more of their body weight ...
Sep 26, 2024
0
0
Individuals who received a once-a-day oral weight loss drug lost up to 13% of their body weight over three months, according to a presentation at the annual meeting of the European Association for the Study of Diabetes (EASD), ...
Sep 10, 2024
0
1
An experimental new weight loss pill from Danish pharmaceutical giant Novo Nordisk could be twice as effective as its blockbuster Ozempic and Wegovy jabs, early results from a small trial have suggested, sending the firm's ...
Mar 8, 2024
0
1
Of the 38 million Americans who have diabetes, at least 90% have type 2, according to the Centers for Disease Control and Prevention. Type 2 diabetes occurs over time and is characterized by a loss of the cells in the pancreas ...
Feb 29, 2024
0
17
Purdue University researchers have taken the first steps to treat Alzheimer's disease, Parkinson's disease and Type 2 diabetes by creating multiple patent-pending compounds shown to inhibit protein aggregation associated ...
Jan 19, 2024
0
22
